Harvard School of Public Health have enlisted the help of Paper Tiger on many projects. Most recently we teamed up on the ToPCaP (Transdisciplinary Prostate Cancer Partnership), and PaCT (Partnership for Cohort Research & Training) to help translate what it is they do in a simple, easy to understand way.
We’re currently embarking on yet another project with our friends at HSPH and look forward to it launching in the Spring. However, in the meantime… do you like apples?
A chronic disease tsunami is coming to Africa. Aid to Africa has focused on infections such as malaria, TB, and HIV. But such efforts will soon be overshadowed by the swirling sea of emerging modern diseases similar to those seen in high-income countries such as heart disease, mental illness, cancer, diabetes, and obesity. By 2030, according to the WHO, three of the top four causes of death in low-income countries will be heart disease, stroke, and chronic lung disease. Cohort studies enroll tens of thousands of people who are asked questions about what they eat, how much they exercise and smoke, and their family and reproductive histories. These are correlated with information from biological samples. However, Africa, home to nearly one billion people, has no large cohort studies similar to those in the US and Europe that look at chronic diseases. (From the HSPH website)
An epidemiologist at the Harvard School of Public Health and a pathologist at Dana Farber Cancer Institute came to the conclusion that the important scientific questions relating to prostate cancer could not be found in either the molecular pathology lab or in epidemiology population studies alone. To address this shortcoming, in 2008 they created the novel team now known as ToPCaP (Transdisciplinary Prostate Cancer Partnership), which integrates molecular pathology and large-scale epidemiological studies. (From topcapteam.org)